CFX · Categories · M&A
CFX - Mergers and acquisitions
Colfax Corporation (CFX) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for CFX
- DJO® Acquires MedShape, Inc.Acquisition expands foot and ankle business and adds innovative shape memory technologies DJO, a subsidiary of Colfax Corporation (NYSE:CFX) and a leading global provider of medical technologies to get and keep people moving, today announced that it has completed the acquisition of MedShape, Inc., a privately held orthopedic medical device company founded in 2005. MedShape® provides innovative surgical solutions for foot and ankle surgeons using its patented superelastic nickel titanium (NiTiNOL) shape memory alloy and shape memory polymer technologies. The acquired business' portfolio includes innovative devices for fracture fixation, joint fusion and soft tissue injury repair that utili
- DJO® Acquires Trilliant SurgicalDALLAS--(BUSINESS WIRE)--DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical’s leading product technologies and clinical efficacy supports DJO’s focused expansion into the adjacent high-growth $1 billion US foot and ankle market. In addition to having a broad product portfolio that covers the full universe of foot recon/fixation procedures, Trilliant Surgical is the only provider of the novel Arsenal Foot Plating System™. With unique features designed for greater flexibi
- DJO® Acquires LiteCure Laser TherapyDALLAS--(BUSINESS WIRE)--DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of LiteCure®, the market leader in therapeutic laser technology for human and animal health. This purchase further extends DJO’s strength as the global market leader in recovery sciences and allows the company to deliver unparalleled innovation to its customers and their patients. “The LiteCure portfolio was a natural fit for the DJO Recovery Sciences business, bringing together a joint passion for innovation and clinically proven technology,” said Brady Shirley, DJO CEO. “The acquisition will strengthen our